FDG-PET imaging helps identify pathological tissue boundaries in pediatric focal cortical dysplasia surgery
A study of 14 children with focal cortical dysplasia found that areas of reduced glucose metabolism on FDG-PET scans contain pathological brain tissue, with more severe pathology concentrated at the lesion center and milder changes at the borders. The research suggests that including these surrounding hypometabolic regions in surgical resections may improve outcomes. All 14 patients achieved seizure freedom after surgery, supporting the clinical utility of this imaging-guided approach.
Researchers analyzed tissue samples from 14 children with intractable focal epilepsy caused by focal cortical dysplasia (FCD) who underwent surgery guided by FDG-PET imaging. The study examined 136 tissue specimens collected from both the center and borders of areas showing reduced glucose metabolism on PET scans. Results showed a gradient of pathology: 75% of central specimens contained pathological changes (59% with frank FCD, 16% with dysmorphic neurons), while 62% of border specimens showed pathology (31% frank FCD, 31% dysmorphic neurons). Statistical modeling confirmed that frank FCD was significantly more concentrated in the lesion epicenter, while dysmorphic neurons appeared in both locations. Importantly, all 14 patients achieved complete seizure freedom at one-year follow-up with no long-term neurological complications, suggesting that including FDG-PET-identified hypometabolic regions in surgical resections improves outcomes by removing more epileptogenic tissue.
Limitations & open questions
The study's limitations include its small sample size (n=14), retrospective design, and lack of a control group for comparison. The generalizability to other epilepsy types or adult populations remains unclear. Long-term follow-up beyond one year and comparison with surgery guided by other imaging modalities alone would strengthen the findings.
What different sources said
- bioRxivCenter
Pathology in resected areas of FDG PET hypometabolism in pediatric epilepsy patients with focal cortical dysplasia
Related
Study reveals IDH1 enzyme's role in cardiac metabolic adaptation during cancer-related stress
Researchers discovered that isocitrate dehydrogenase 1 (IDH1) helps the heart adapt to metabolic stress caused by cancer-related mutations through a previously unknown reductive metabolic pathway. The study used stable isotope tracing and genetic knockout models in rat and mouse heart tissue to show that when mitochondrial metabolism is impaired, IDH1 redirects carbon flux toward glutamine-derived citrate formation. This finding expands understanding of how cardiac metabolism responds to oncometabolic stress and may have implications for managing cardiovascular complications in cancer patients.
AI Framework Reveals How β-Arrestin 1 Protein Changes Shape During Activation
Researchers used a transformer-based artificial intelligence model to analyze how the β-arrestin 1 protein's tail region reorganizes when activated by cell surface receptors. The study examined molecular dynamics simulations comparing the protein in resting and active states, uncovering previously unknown conformational changes. This work could improve understanding of how cells regulate signaling pathways involved in numerous physiological and disease processes.
Study Links Pancreatic Cancer Tissue Stiffness to Tumor Progression and Patient Survival
Researchers combined imaging scans and laboratory tissue analysis to show that pancreatic cancer tumors with greater stiffness—driven by dense collagen buildup—correlate with worse patient survival outcomes. The study of nine patients found that magnetic resonance elastography, a non-invasive imaging technique, can detect mechanical properties that reflect underlying tumor biology. These findings suggest that measuring tissue stiffness through imaging could help doctors better characterize pancreatic cancer and guide treatment decisions.